Are MNMD's operating losses narrowing recently?
5/9/2025 03:39am
Mind Medicine (MNMD) has not shown a trend of narrowing operating losses recently. In fact, the company's operating income for the fiscal quarter ending December 31, 2024, was -$29.84 million. This indicates a significant operating loss for that period, and without further information on subsequent quarters, it is not possible to determine if the losses are narrowing.
|code|Ticker|Name|Date|Operating Income YoY|Operating Income|market_code|
|---|---|---|---|---|---|---|
|MNMD|MNMD.O|Mind Medicine|2024 Q1|-7.171314741035857|-2.0982E7|185|
|MNMD|MNMD.O|Mind Medicine|2024 Q2|21.759408746815915|-2.1808E7|185|
|MNMD|MNMD.O|Mind Medicine|2024 Q3|-7.6223536889453865|-2.2012E7|185|
|MNMD|MNMD.O|Mind Medicine|2024 Q4|-40.08920187793427|-2.9839E7|185|